Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/SNN
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Smith & Nephew plc (SNN) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

SNN trades at $26.69, down 2.95% on the day, with a bearish technical signal but improving fundamentals. Recent earnings show three consecutive beats, with Q2 2026 EPS of $0.946 exceeding expectations. Revenue grew to $6.16B in 2025, and net income margin expanded to 10.08%. The company announced a $0.31 dividend payable in November 2026 and is advancing surgical robotics through partnerships.
Outlook is mixed: strong profitability and innovation support upside, but analyst caution and U.S. market weakness pose risks. The stock's valuation metrics like P/E of 18.24 appear reasonable, yet investor sentiment remains guarded due to recent guidance cuts and CFO departure, highlighting execution challenges.
Read full analysis

Key Stats

  • Market Cap
    $11.25B
  • Volume
    1,794,373
  • Sector
    Health
  • 52W High
    $37.17
  • 52W Low
    $26.82
  • Typical Hold Time
    119 Days
  • Enterprise Value
    $14.28B
  • Div Yield
    2.96%
  • Trading Activity
    0% Sell | 100% Buy
$26.66
52W Low: $26.66
24 Sep 2026
52W High: $37.17
22 Oct 2025

Track Smith & Nephew plc (SNN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Smith & Nephew plc has traded between a low of $26.66 and a high of $37.17, highlighting its annual price range. Buy and sell Smith & Nephew plc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Most Recent News

Content is generated by Aura AI

OceanaGold's strong drilling boosts Waihi resource outlook; processing expansion eyed for 2027 report

OceanaGold reported strong drilling results at its Waihi project, supporting resource conversion and potential reserve growth. The company is considering expanding processing capacity from 0.8 to 1.2 million tons annually, which could allow concurren...

Market News
4 hours ago
Proactive Investors
Bullish
news icon
OceanaGold's strong drilling boosts Waihi resource outlook; processing expansion eyed for 2027 report

Roku set to complete Fox deal in H1 2027, Wedbush sees $155 target amid strong standalone growth

Wedbush expects Roku to clear regulatory hurdles and close its acquisition of Fox Corporation in the first half of 2027. The broker maintained a $155 price target and neutral rating after meeting Roku management, citing strong standalone business per...

Market News
4 hours ago
Proactive Investors
Bullish
news icon
Roku set to complete Fox deal in H1 2027, Wedbush sees $155 target amid strong standalone growth

Bank of America raises revenue and margin forecasts for AI firm Nebius amid capacity expansion.

Bank of America upgraded its revenue forecasts for Nebius Group NV, an AI infrastructure company, projecting $12.7 billion in fiscal 2027 and $27.3 billion in 2028, surpassing Wall Street estimates. The bank highlighted Nebius' strategy of using long...

Market News
4 hours ago
Proactive Investors
Bullish
news icon
Bank of America raises revenue and margin forecasts for AI firm Nebius amid capacity expansion.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $11.25B
  • Volume
    1,794,373
  • Sector
    Health
  • 52W High
    $37.17
  • 52W Low
    $26.82
  • Typical Hold Time
    119 Days
  • Enterprise Value
    $14.28B
  • Div Yield
    2.96%
  • Trading Activity
    0% Sell | 100% Buy
$26.66
52W Low: $26.66
24 Sep 2026
52W High: $37.17
22 Oct 2025

Track Smith & Nephew plc (SNN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Smith & Nephew plc has traded between a low of $26.66 and a high of $37.17, highlighting its annual price range. Buy and sell Smith & Nephew plc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!